Neuropathic-like Nociception and Spinal Cord Neuroinflammation Are Dependent on the TRPA1 Channel in Multiple Sclerosis Models in Mice
暂无分享,去创建一个
D. Dalenogare | P. Geppetti | G. Trevisan | R. Nassini | G. de Siena | F. De Logu | Daniel Souza Monteiro de Araújo | L. Landini | Mustafa Titiz | Francesco De Logu | G. De Siena
[1] S. M. Oliveira,et al. TRPA1 mediates headache-related cephalic allodynia in a mouse model of relapsing-remitting multiple sclerosis. , 2021, Pain.
[2] K. Kuter,et al. Beyond the GFAP-Astrocyte Protein Markers in the Brain , 2021, Biomolecules.
[3] M. Aliomrani,et al. Analysis of platelet-derived growth factor receptor A and oligodendrocyte transcription factor 2 markers following Hydroxychloroquine administration in animal induced multiple sclerosis model , 2021, Metabolic Brain Disease.
[4] S. M. Oliveira,et al. Periorbital Nociception in a Progressive Multiple Sclerosis Mouse Model Is Dependent on TRPA1 Channel Activation , 2021, Pharmaceuticals.
[5] M. M. Trachez,et al. Antinociceptive Effect of Lodenafil Carbonate in Rodent Models of Inflammatory Pain and Spinal Nerve Ligation-Induced Neuropathic Pain , 2021, Journal of pain research.
[6] Jung Hoon Jung,et al. Functional Importance of Transient Receptor Potential (TRP) Channels in Neurological Disorders , 2021, Frontiers in Cell and Developmental Biology.
[7] S. Maier,et al. Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain , 2020, Brain, Behavior, and Immunity.
[8] A. Piotrowska,et al. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy , 2020, Frontiers in Immunology.
[9] F. Quintana,et al. Astrocyte Crosstalk in CNS Inflammation , 2020, Neuron.
[10] P. C. Silveira,et al. Macrophages and Schwann cell TRPA1 mediate chronic allodynia in a mouse model of complex regional pain syndrome type I , 2020, Brain, Behavior, and Immunity.
[11] S. M. Oliveira,et al. Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation , 2020, Molecular Neurobiology.
[12] S. M. Oliveira,et al. TRPA1 activation mediates nociception behaviors in a mouse model of relapsing-remitting experimental autoimmune encephalomyelitis , 2020, Experimental Neurology.
[13] Z. Berente,et al. Investigation of Cuprizone-Induced Demyelination in mGFAP-Driven Conditional Transient Receptor Potential Ankyrin 1 (TRPA1) Receptor Knockout Mice , 2019, Cells.
[14] N. Bunnett,et al. Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice. , 2019, The Journal of clinical investigation.
[15] Changsheng Huang,et al. SETD7 mediates spinal microgliosis and neuropathic pain in a rat model of peripheral nerve injury , 2019, Brain, Behavior, and Immunity.
[16] Xu Wang,et al. Astrocytes in multiple sclerosis and experimental autoimmune encephalomyelitis: Star-shaped cells illuminating the darkness of CNS autoimmunity , 2019, Brain, Behavior, and Immunity.
[17] H. Hartung,et al. The Molecular Basis for Remyelination Failure in Multiple Sclerosis , 2019, Cells.
[18] J. Olesen,et al. Effect of TRPA1 activator allyl isothiocyanate (AITC) on rat dural and pial arteries , 2019, Pharmacological reports : PR.
[19] R. Brambilla. The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis , 2019, Acta Neuropathologica.
[20] I. Bjelobaba,et al. Animal models of multiple sclerosis: Focus on experimental autoimmune encephalomyelitis , 2018, Journal of neuroscience research.
[21] O. Ciccarelli,et al. Multiple sclerosis , 2018, The Lancet.
[22] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[23] D. Nosi,et al. Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice , 2017, Nature Communications.
[24] R. Donahue,et al. Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn , 2017, Pain.
[25] A. Buisson,et al. TRPA1 channels promote astrocytic Ca2+ hyperactivity and synaptic dysfunction mediated by oligomeric forms of amyloid-β peptide , 2017, Molecular Neurodegeneration.
[26] J. Calixto,et al. The transient receptor potential ankyrin‐1 mediates mechanical hyperalgesia induced by the activation of B1 receptor in mice , 2017, Biochemical pharmacology.
[27] D. Goldstein,et al. Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy , 2017, PloS one.
[28] É. Szőke,et al. TRPA1 deficiency is protective in cuprizone‐induced demyelination—A new target against oligodendrocyte apoptosis , 2016, Glia.
[29] S. Benemei,et al. TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress. , 2016, Brain : a journal of neurology.
[30] Hui-Ching Lin,et al. Role of transient receptor potential ankyrin 1 channels in Alzheimer’s disease , 2016, Journal of Neuroinflammation.
[31] B. Przewłocka,et al. Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model , 2016, Neuropharmacology.
[32] D. Attwell,et al. Proton-gated Ca2+-permeable TRP channels damage myelin in conditions mimicking ischaemia , 2015, Nature.
[33] O. Krizanova,et al. Calcium and ROS: A mutual interplay , 2015, Redox biology.
[34] John C McGrath,et al. Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP , 2015, British journal of pharmacology.
[35] T. Woodruff,et al. Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord , 2015, Pharmacology research & perspectives.
[36] C. Brosnan,et al. Loss of Allograft Inflammatory Factor-1 Ameliorates Experimental Autoimmune Encephalomyelitis by Limiting Encephalitogenic CD4 T-Cell Expansion , 2015, Molecular medicine.
[37] T. Woodruff,et al. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods , 2014, Pharmacology Biochemistry and Behavior.
[38] Jeffrey A. Cohen,et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.
[39] J. Ferreira,et al. Action of Phα1β, a peptide from the venom of the spider Phoneutria nigriventer, on the analgesic and adverse effects caused by morphine in mice. , 2014, The journal of pain : official journal of the American Pain Society.
[40] Alan J. Man,et al. Neuronopathy in the motor neocortex in a chronic model of multiple sclerosis. , 2014, Journal of neuropathology and experimental neurology.
[41] Maiken Nedergaard,et al. Glia and pain: Is chronic pain a gliopathy? , 2013, PAIN®.
[42] J. Calixto,et al. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: Evidence for the involvement of astrocytes , 2013, Neurobiology of Disease.
[43] M. Macleod,et al. Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis , 2013, PAIN®.
[44] G. Aldini,et al. Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade. , 2013, Cancer research.
[45] Y. Sauve,et al. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE) , 2013, Experimental Neurology.
[46] Jing Wang,et al. L6 spinal nerve ligation produces prolonged development of mechanical allodynia and gradual increase of GFAP on ipsilateral dorsal horn , 2013, Acta Neurochirurgica.
[47] K. Noguchi,et al. An ultrastructural evidence for the expression of transient receptor potential ankyrin 1 (TRPA1) in astrocytes in the rat trigeminal caudal nucleus , 2012, Journal of Chemical Neuroanatomy.
[48] M. Fernandes,et al. The functions of TRPA1 and TRPV1: moving away from sensory nerves , 2012, British journal of pharmacology.
[49] Xiaohong Yuan,et al. Effects of Glial Cell Line-Derived Neurotrophic Factor Intrathecal Injection on Spinal Dorsal Horn Glial Fibrillary Acidic Protein Expression in a Rat Model of Neuropathic Pain , 2012, The International journal of neuroscience.
[50] B. Nilius,et al. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism , 2012, Pflügers Archiv - European Journal of Physiology.
[51] Baljit S. Khakh,et al. TRPA1 channels regulate astrocyte resting calcium levels and inhibitory synapse efficacy via GAT-3 , 2011, Nature Neuroscience.
[52] C. Constantinescu,et al. Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) , 2011, British journal of pharmacology.
[53] C. Solaro,et al. Management of pain in multiple sclerosis: a pharmacological approach , 2011, Nature Reviews Neurology.
[54] B. Nilius,et al. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation , 2011, PAIN®.
[55] David M Frim,et al. Olig1 is expressed in human oligodendrocytes during maturation and regeneration , 2011, Glia.
[56] N. Pivovarova,et al. Calcium‐dependent mitochondrial function and dysfunction in neurons , 2010, The FEBS journal.
[57] Camille J. Olechowski,et al. A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE) , 2010, PAIN.
[58] Camille J. Olechowski,et al. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE) , 2009, PAIN®.
[59] Shigeo Kobayashi,et al. Activation of transient receptor potential ankyrin 1 by hydrogen peroxide , 2008, The European journal of neuroscience.
[60] A. Basbaum,et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1 , 2007, Proceedings of the National Academy of Sciences.
[61] Clifford J. Woolf,et al. TRPA1 Contributes to Cold, Mechanical, and Chemical Nociception but Is Not Essential for Hair-Cell Transduction , 2006, Neuron.
[62] Peter McIntyre,et al. ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures , 2003, Cell.
[63] T. Yaksh,et al. Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.
[64] M. Zimmermann,et al. Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.
[65] L. B,et al. Examination of Ligand-Receptor Interactions amongst Different Multiple Sclerosis Lesion Types , 2022, SunText Review of Neuroscience & Psychology.
[66] B. Lucke-Wold,et al. Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection. , 2017, Advances in experimental medicine and biology.
[67] S. Benemei,et al. The TRPA1 channel in inflammatory and neuropathic pain and migraine. , 2014, Reviews of physiology, biochemistry and pharmacology.
[68] A. Akopian. Regulation of nociceptive transmission at the periphery via TRPA1-TRPV1 interactions. , 2011, Current pharmaceutical biotechnology.
[69] W. Dixon,et al. Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.